International Medical Journal Medicus (IMJM) is an international peer reviewed journal that publishes papers from all fields of health sciences. Furthermore, the journal intends to bring educational material of high
quality to its members for continuous medical education (CME), by publishing original research, review papers, case reports, brief communications, literature summary articles and editorials.
The language of publication is English and Albanian (the Editorial Board may decide whether other language will be used for publications). Authors are requested to have their paper proofread and edited for the respective language.
Please use standard-sized paper and submit your article in the following standard (A4) format: Word for Windows, Times New Roman 12. Set all margins to be 3 cm. All materials to be tipped double –spaced.
The Journal allows submission of no more than one article,as an author, and at most two, being a co-author per issuance.
I). Manuscript Types
International Medical Journal Medicus (IMJM) publishes five types of manuscripts:
Original research paper – up to 4000 words and no more than 6 tables and / or graphs / pictures; Each manuscript should clearly state an objective or hypothesis; the design and methods (including the study setting and dates, patients or participants with inclusion and exclusion criteria and/ or participation or response rates, or data sources, and how these were selected for the study); the essential features of any interventions; the main outcome measures; the main results of the study; a comment section placing the results in context with the published literature and addressing study limitations; and the conclusions. Criteria include relevance of research question, quality of design, sound implementation procedures, thorough outcome analysis of research findings, and implications for practice and policy.
Review paper – up to 3000 words and no more than 4 tables and / or figures / images. They should include up to 50 references. The abstract for reviews should be unstructured and should contain no more than 200 words. The review should include a broad update of recent developments (from the past 3-5 years) and their likely clinical applications in primary and secondary care. It should stimulate readers to read further and should indicate other sources of information, including web based information.
Brief communication – up to 2000 words and a maximum of 3 tables and / or figures / images and 10 references.
Case reports have a maximum of 1500 words and should include: introduction, aim, case description, discussion/conclusion and up to 10 references.
Book reviews –up to 1000 words provide reviews of current books and other publications of interest to individuals involved in public health and medicine. Book reviews are solicited by invitation; however, persons interested in doing a review may contact the editors.
II). Manuscript Preparation
Title page – provide the title of the paper; the name(s) of the author(s), including the first and last name(s) ; the name of the department and institution in which the work was done; the institutional affiliation of each author; and the name and address of the author to whom reprint requests should be addressed (including e- mail).
Abstract should be written with a maximum of 150 words for unstructured abstracts and 250 words for structured abstracts. Abstract must be sent in the language of the paper and in English. Containing parts: Abstract need to hold title, full name(s) and surnames(s) of the author(s), work institution and for structured abstracts: Objective(s) of study or research, Methods, Results and Conclusions; basic procedures, such as selection of subjects or laboratory animals, observational and analytical methods, then, the main findings/results and the main conclusions. Abstract must have no quoted references. Three to five key words or short phrases should be added to the bottom of the abstract page.
III). Full text
1. Introduction: Provide a context or background for the study (that is, the nature of the problem and its significance). Emphasize the level of knowledge about the problem at the beginning of the investigation. Explain your hypotheses and the plan to test them, and describe your aims.Do not include data or conclusions from the work being reported.
2. Methods & Material: In this section, details regarding the material, samples, methods and equipment used in the study should be included, so that another individual could repeat the work. Describe your selection of the observational or experimental participants (patients or laboratory animals, including controls) clearly, including eligibility and exclusion criteria. The guiding principle should be clarity about how and why a study was done in a
particular way. If a particular method used is well known then there is no need to give a complete description. You can reference the paper in which it was first described and mentioned any modifications you have made. Give the reasons for using them, and evaluate their limitations. Subsequently, the period of research and the institution where it was conducted should be clearly mentioned. Finally, describe how you analysed your data , including the statistical methods and software package used. Papers covering research on human or animal subjects should contain a statement indicating patient permission and clearance by the institute research or ethics committee or
animal experimentation committee. Authors submitting review manuscripts should include a section describing the methods used for locating, selecting, extracting, and synthesizing data.
Statistics: Describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Avoid relying solely on statistical hypothesis testing, such as p values, which fail to convey important information about effect size. Give details about the randomization and describe the methods and success of observations while using blinded trials. Define statistical terms, abbreviations, and most symbols.
3. Results: This section should make your findings clear. Present your results in logical sequence in the text, tables, and illustrations, giving the main or most important findings firs. Emphasize or summarize only the most
important observations. When data are summarized in the Results section, give numeric results not only as derivatives (for example, percentages) but also as the absolute numbers from which the derivatives were calculated, and specify the statistical methods used to analyse them. Do not combine the Results and Discussion sections for full-length papers.
a) Tables: Each table should be inserted at the point of the text where they have to be placed logically, typed by the same rules as for the full text. Do not send tables as photographs. Each table should be cited in the text. Tables should be numbered so that they will be in sequence with references cited in the text. Provide a brief explanation of the table below the title. Any additional explanations, legends or explanations of nonstandard abbreviations should be placed immediately below the table.
b) If photographs of patients are used, either the subjects should not be identifiable or their pictures must be accompanied by written permission to use the figure. Permission forms are available from the Editor.
c) Legends for Illustrations (Figures): The legend of a table has to be placed above the table. The reference of a table, which has been taken from another publication, must be placed below the table. (It is the author’s responsibility to obtain the permission of reproduction from the publishers of the publication). Figure legends are to be placed at the end of the paper. The reference of a figure taken from another publication stands at the end of
the legend. (Permission of reproduction must be obtained from the publishers of this publication).
4. Discussion: This section should not repeat results. The discussion section should discuss study findings, and interpret them in the context of other trials reported in the literature providing evidence or counterevidence. In this way the validity of the results and the significance of the conclusions for the application in further research are assessed, with respect to the hypothesis, relevance of methods, and significance of differences observed .Negative findings are just as important to the development of future ideas as the positive ones. Link the conclusions with the goals of the study but avoid unqualified statements and conclusions not adequately supported
by the data. Avoid claiming priority or alluding to work that has not been compared.
References: Quoting references must be on the scale, in which they are really used. Quoting most recent literature is recommended. Only published articles, (or articles accepted for publication), can used as a reference. Not published observations and personal notifications need to be in text in buckets. Showing references should be as how they appear in the text. References cited in tables or pictures are also numbered according to the quoting order. All references should be compiled at the end of the article in the Vancouver style or PubMed style; (www.icmje.org/urm_main.html). Consult Index Medicus or PubMed (http:/ / www.ncbi.nlm.nih.gov/ entrees/ ) for standard journal abbreviations. Please refer to the examples below, as follows:
1. Lahita R, Kluger J, Drayer DE, Koffler D, Reidenberg MM. Antibodies to nuclear antigens in patients treated
with procainamide or acetyl procainamide. N Engl J Med 1979; 301:1382-5.
3. Murray C, Lopez A. Alternative projections of mortality and disability by cause 1990-2020: global burden of
disease study. Lancet 1997; 349: 1498-504.
Books and other monographs:
4. Colson JH, Tamour NJJ. Sports in juries and their treatment. 2nd ed. London: S. Paul, 2006.
5.Department of Health. National service framework for coronary heart disease. London: DoH, 2000.
www.doh.gov.uk/nsf/coronary.htm (accessed 6 Jun 2003).
Acknowledgements: You may wish to acknowledge people who have helped you. These can range from those who supported you with experimental techniques to those who read or offered advice on your final manuscrip.
The international generic names should be used for all drugs. When proprietary brands are used in research, include the brand name in parentheses in the Methods section.
Obtaining written permissions for material such as figures, tables, art, and extensive quotes taken directly, or adapted in minor ways from another source is the author s responsibility, as is payment of any fees the copyright
holder may require. Authors should never assume that material taken from software or downloaded from the Internet may be used without obtaining permission. Each source must be investigated on a case-by-case basis.
Failure to obtain permission will result in either removal of the particular item or rejection of the article for publication in the journal. Any practice of plagiarism will not be tolerated regarding submitted articles.
Acceptance Criteria and Conditions of Publication
Authors are encouraged to write in a manner that is maximally communicative, interesting, and informative. Manuscripts should be submitted solely to the International Medical Journal Medicus (Medicus) The authors attest that their contribution has neither been published nor submitted for publication elsewhere, until the editorial procedure is over. If an article has appeared previously in any form, authors must clearly indicate this in their cover letter. Include copies of potentially duplicative material that has been previously published and provide links to duplicative material on the Internet.
Manuscripts should be submitted on-line on: www.imjm.mk
Editorial board can be contacted for any additional information of clarification to the Editorial Office:
Prof. Dr. Nevzat Elezi,
Str. Mehmed Pashe Deralla, No 16, 1200 Tetovo,
e- mail: firstname.lastname@example.org
The submission should be accompanied with a Letter to the Editors (a separate Word document) stating the following:
– Manuscript type (original research; review; brief communication; case report; book review),
– Major findings of the research work,
– Novelty and relevance of the manuscript.
All authors must submit a statement of conflict of interest to be published at the end of their article (conflict of Interest: None declared)
Authors will be notified about editorial decision no later than 3 months after the date of manuscript
The copyright of all material published is vested in the International Medical Journal Medicus